Rocket Pharmaceuticals (RCKT) Competitors $13.04 -0.12 (-0.91%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RCKT vs. AUPH, RCUS, YMAB, MRSN, AMRN, BHVN, ACLX, BBIO, RARE, and OGNShould you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include Aurinia Pharmaceuticals (AUPH), Arcus Biosciences (RCUS), Y-mAbs Therapeutics (YMAB), Mersana Therapeutics (MRSN), Amarin (AMRN), Biohaven (BHVN), Arcellx (ACLX), BridgeBio Pharma (BBIO), Ultragenyx Pharmaceutical (RARE), and Organon & Co. (OGN). These companies are all part of the "medical" sector. Rocket Pharmaceuticals vs. Aurinia Pharmaceuticals Arcus Biosciences Y-mAbs Therapeutics Mersana Therapeutics Amarin Biohaven Arcellx BridgeBio Pharma Ultragenyx Pharmaceutical Organon & Co. Aurinia Pharmaceuticals (NASDAQ:AUPH) and Rocket Pharmaceuticals (NASDAQ:RCKT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, community ranking, profitability and media sentiment. Does the MarketBeat Community favor AUPH or RCKT? Aurinia Pharmaceuticals received 182 more outperform votes than Rocket Pharmaceuticals when rated by MarketBeat users. Likewise, 73.21% of users gave Aurinia Pharmaceuticals an outperform vote while only 73.12% of users gave Rocket Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAurinia PharmaceuticalsOutperform Votes57173.21% Underperform Votes20926.79% Rocket PharmaceuticalsOutperform Votes38973.12% Underperform Votes14326.88% Which has more risk and volatility, AUPH or RCKT? Aurinia Pharmaceuticals has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, Rocket Pharmaceuticals has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500. Is AUPH or RCKT more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to Aurinia Pharmaceuticals' net margin of -10.23%. Aurinia Pharmaceuticals' return on equity of -4.41% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aurinia Pharmaceuticals-10.23% -4.41% -3.07% Rocket Pharmaceuticals N/A -62.62%-54.17% Which has preferable earnings and valuation, AUPH or RCKT? Aurinia Pharmaceuticals has higher revenue and earnings than Rocket Pharmaceuticals. Aurinia Pharmaceuticals is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia Pharmaceuticals$175.51M6.72-$78.02M-$0.15-54.93Rocket PharmaceuticalsN/AN/A-$245.60M-$2.75-4.74 Do institutionals & insiders have more ownership in AUPH or RCKT? 36.8% of Aurinia Pharmaceuticals shares are owned by institutional investors. Comparatively, 98.4% of Rocket Pharmaceuticals shares are owned by institutional investors. 4.3% of Aurinia Pharmaceuticals shares are owned by insiders. Comparatively, 28.5% of Rocket Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer AUPH or RCKT? In the previous week, Rocket Pharmaceuticals had 17 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 25 mentions for Rocket Pharmaceuticals and 8 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.86 beat Rocket Pharmaceuticals' score of 0.32 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurinia Pharmaceuticals 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rocket Pharmaceuticals 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer AUPH or RCKT? Aurinia Pharmaceuticals currently has a consensus target price of $10.00, indicating a potential upside of 21.36%. Rocket Pharmaceuticals has a consensus target price of $51.00, indicating a potential upside of 291.10%. Given Rocket Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Rocket Pharmaceuticals is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91 SummaryAurinia Pharmaceuticals beats Rocket Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKT vs. The Competition Export to ExcelMetricRocket PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19B$6.45B$5.04B$8.81BDividend YieldN/A8.11%5.16%4.07%P/E Ratio-4.7410.78130.5317.82Price / SalesN/A243.701,183.8674.55Price / CashN/A22.1633.6132.53Price / Book2.395.474.684.68Net Income-$245.60M$153.61M$119.23M$226.08M7 Day Performance-12.01%-2.00%-1.83%-1.04%1 Month Performance-25.99%-7.46%-3.61%1.04%1 Year Performance-40.37%31.82%31.74%26.28% Rocket Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCKTRocket Pharmaceuticals4.4174 of 5 stars$13.04-0.9%$51.00+291.1%-40.8%$1.20BN/A-4.74240Analyst ForecastAUPHAurinia Pharmaceuticals1.6758 of 5 stars$8.24+1.4%$10.00+21.4%-10.8%$1.16B$175.51M0.00300RCUSArcus Biosciences2.677 of 5 stars$14.62+0.8%$34.00+132.6%+4.7%$1.33B$117M0.00500YMABY-mAbs Therapeutics3.3273 of 5 stars$10.54-2.9%$21.38+102.8%+100.8%$486.41M$84.82M0.00150Analyst ForecastMRSNMersana Therapeutics4.3673 of 5 stars$2.22flat$6.00+170.3%+38.8%$274.24M$36.85M0.00150Analyst RevisionAMRNAmarin0.1111 of 5 stars$0.49flatN/A-37.4%$201.52M$306.91M0.00360Negative NewsBHVNBiohaven3.9152 of 5 stars$46.81+1.1%$63.42+35.5%+53.0%$4.73B$462.51M-5.01239ACLXArcellx2.9241 of 5 stars$87.22-0.4%$103.08+18.2%+65.8%$4.72B$155.82M-122.85130Short Interest ↓BBIOBridgeBio Pharma4.5782 of 5 stars$23.04+2.2%$47.57+106.5%-21.2%$4.35B$9.30M-9.56400Insider TradeAnalyst RevisionRAREUltragenyx Pharmaceutical4.6401 of 5 stars$46.40+2.8%$86.69+86.8%+17.9%$4.17B$434.25M0.001,276OGNOrganon & Co.4.7217 of 5 stars$14.73+0.9%$21.33+44.9%+31.6%$3.76B$6.26B2.9210,000 Related Companies and Tools Related Companies AUPH Competitors RCUS Competitors YMAB Competitors MRSN Competitors AMRN Competitors BHVN Competitors ACLX Competitors BBIO Competitors RARE Competitors OGN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCKT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
